Balanced news tone
News Sentiment
688506 sentiment intelligence
Sichuan Biokin Pharmaceutical Co.,Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
+0.7% over one week, +36.4% over four weeks, trend inactive, and materially above fair value.
Chinese drug developer Biokin postpones Hong Kong listing
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Chinese drug developer Biokin postpones Hong Kong listing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Nov 2025 08:00
- Source
- South China Morning Post
BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jan 2025 08:00
- Source
- Fierce Biotech